Matrix metalloproteinases (MMPs) are increased in the synthesis was increased in the CSF of multiple sclerosis patients but not in that of DNO patients. Zymography, CSF of patients with multiple sclerosis. Devic's neuromyelitis optica (DNO) is a demyelinating syndrome that reverse zymography and ELISA (enzyme-linked immunosorbent assay) were used to measure gelatinase A involves the optic nerve and cervical cord but differs pathologically from multiple sclerosis. Therefore, we (MMP-2), gelatinase B (MMP-9) and tissue inhibitors of metalloproteinases (TIMPs). Zymograms showed that hypothesized that the type of inflammatory reaction that causes MMPs to be elevated in multiple sclerosis would multiple sclerosis patients had elevated MMP-9 compared with DNO patients and controls (P < 0.05). TIMP-1 and be absent in patients with DNO. CSF was collected from 23 patients with relapsing-remitting or secondary TIMP-2 levels were similar in all three groups. We conclude that multiple sclerosis patients have higher progressive multiple sclerosis, all of whom were experiencing acute symptoms, from seven patients with MMP-9 levels in the CSF than patients with DNO, which supports the different pathological mechanisms of these DNO, and from seven normal volunteers. Diagnoses were made according to current criteria on the basis of clinical diseases. manifestations, imaging results and CSF studies. IgG Keywords: gelatinase B; Devic's neuromyelitis optica; matrix metalloproteinases; multiple sclerosis; tissue inhibitors of metalloproteinases Abbreviations: BBB ϭ blood-brain barrier; DNO ϭ Devic's neuromyelitis optica; ELISA ϭ enzyme-linked immunosorbent assay; MMP ϭ matrix metalloproteinase; TIMP ϭ tissue inhibitor of metalloproteinase
Introduction
Multiple sclerosis and Devic's neuromyelitis optica (DNO) and necrosis and cavitation in DNO are poorly understood. Elucidation of these mechanisms is vital for the development are neuroinflammatory syndromes that have been separated on the basis of clinical manifestations, imaging, CSF of rational, science-based therapies, which are required because of the severe, often fulminate disease course suffered chemistry and pathology (Piccolo et al., 1990; Mandler et al., 1993; Wingerchuk et al., 1999) . Separation of the two by patients with DNO. Proteolytic enzymes have been detected in the CSF and remains controversial, because the mechanisms producing demyelination and axonal transection in multiple sclerosis brain of patients with multiple sclerosis (Rinne and Riekkinen, 1968; Hallpike and Adams, 1969) . Neutral proteases are were done after informed consent had been obtained. All patients had an active disease process that required lumbar increased during acute exacerbation of multiple sclerosis. Matrix metalloproteinases (MMPs) are neutral proteases that puncture and treatment. Subsequently, the multiple sclerosis patients were separated into those with relapsing-remitting attack the extracellular matrix. Patients with multiple sclerosis have elevated levels of the MMP, gelatinase B (MMP-9), in and secondary progressive disease on the basis of a chart review. Diagnoses of multiple sclerosis and DNO were made the CSF (Gijbels et al., 1992; Paemen et al., 1994) , and blood levels of MMP-9 are increased before an acute attack by clinicians experienced in the diagnosis and treatment of multiple sclerosis and of DNO. Multiple sclerosis was of multiple sclerosis (Waubant et al., 1999) . Intracerebral injection of gelatinase A (MMP-2) opens the blood-brain diagnosed by the Poser criteria (Poser et al., 1983) , and DNO was diagnosed as described in an earlier publication (Mandler barrier (BBB) (Rosenberg et al., 1992) . Tumour necrosis factor-α injected into brain induces MMP-9 synthesis, causing et al., 1993) . The study was approved by the Human Research Review Committee at the University of New Mexico, and a delayed opening of the BBB (Rosenberg et al., 1995) . T lymphocytes use MMP-9 to attack the capillary basal complied with NIH Guidelines. All patients gave informed consent for the use of CSF in these assays. lamina, allowing them to cross the BBB (Leppert et al., 1995) . Experimental allergic encephalomyelitis causes an increase in the levels of MMP-9 in the rodent brain, and inhibitors of MMPs block the manifestations of the disease
Zymography
The methods we used for the measurement of the MMPs in in animals Hewson et al., 1995) . Thus, considerable evidence in experimental animals and man the CSF by quantitative zymography have been reported (Kleiner and Stetler-Stevenson, 1994; Rosenberg et al., 1996) . implicates the MMPs in the acute pathophysiology of multiple sclerosis.
Briefly, 5 µl CSF was mixed with 3 µl of 1.5 mM Tris (pH 8.8) and 2 µl of ϫ4 concentrated zymography buffer MMPs are a gene family with 20 members that comprise four major groups differing in protein structure and substrate [0.0625 M Tris-HCl (pH 6.8), 10% glycerol, 2% SDS (sodium dodecyl sulphate) and 0.00125% bromophenol blue]. specificity (Birkedal-Hansen et al., 1993) . The major MMPs identified in the brain include gelatinase A (MMP-2), CSF was analysed with gelatin gel polyacrylamide gels (SDS-PAGE). Ten per cent polyacrylamide gels were stromelysin 1 (MMP-3), matrilysin (MMP-7), gelatinase B (MMP-9) and membrane-type metalloproteinases (Yong et al., prepared [1.5 ml distilled water, 1.18 ml of 1.5 M Tris (pH 8.8), 45 µl of 10% SDS; 1.5 ml acrylamide-bis (30% 1998). Gelatinases (MMP-2 and -9) attack the basal lamina surrounding the blood vessels, altering permeability. MMP-2 T, 2.67% C), 2.2 µ TEMED (l N,N,NЈ,NЈ-tetramethylethylenediamine) and 22 µl ammonium persulphate solution, is a constitutive enzyme that is normally found in the CSF. MMP-9, which is induced during the neuroinflammatory 100 mg/ml], with gelatin (300 µl of 15 mg/ml solution; Sigma G-2500, St Louis, Mo., USA) copolymerized into response, is increased in the CSF of patients with gadoliniumenhancing lesions on MRI; treatment with high-dose the gel matrix. Prestained protein standards and HT1080 fibrosarcoma media, which contains MMP-2 and MMP-9, intravenous methylprednisolone returned the MMP-9 levels to normal (Rosenberg et al., 1996) . Because of the toxicity were run in every gel to determine molecular weights. After electrophoresis, gels were agitated in 2.5% Triton X-100 to of MMPs to tissues, their proteolytic activity is controlled at several levels, including transcription, activation and remove the SDS and restore enzyme activity during incubation. Gels were then incubated for 24 h at 37°C in inhibition. Tissue inhibitors of metalloproteinases (TIMPs) are the main inhibitors. MMPs and TIMPs can be measured 50 ml of 50 mM Tris-HCl (pH 7.6, containing 0.2 M NaCl, 5 mM CaCl 2 , 0.02% Brij-35 and 0.02% sodium azide). in CSF by zymography and reverse zymography, respectively. Enzyme-linked immunoassay (ELISA) methods have been Finally, gels were stained for 1 h in 50% methanol/1% acetic acid with 0.125% Coomassie G blue dye, then destained in developed recently.
Because DNO has different histopathological features and 10% acetic acid. Zones of proteolytic activity were evident as clear bands against a dark blue background. Dried gels lacks the typical neuroinflammatory markers in the CSF that are generally seen in multiple sclerosis, we hypothesized that were scanned (Agfa Duo scanner), and analysed with computer image analysis software (NIH Image, v. 1.56) elevated levels of MMPs that are uncompensated by a rise in TIMPs would be seen in the CSF of patients with multiple running on a Macintosh Power PC computer. Individual lanes were analysed with the electrophoretic gel lane calculation sclerosis but not in that of patients with DNO. option in the program. Standardization was done with an optical density step tablet.
Patients and methods
Patients were selected if they had symptoms suggestive of DNO or clinically active multiple sclerosis; patients with
Reverse zymography
TIMP-1 and TIMP-2 were measured in CSF by quantitative relapsing-remitting and secondary progressive courses of multiple sclerosis were included. CSF was collected from reverse zymography (Oliver et al., 1997) . Briefly, samples of CSF (5 µl) were mixed with 3 µl of 1.5 mM Tris patients during a diagnostic lumbar puncture, and analyses acute symptoms at the time of the lumbar puncture. The mouse TIMP-2 and mouse TIMP-3) were prepared similarly.
seven patients with DNO all had optic neuritis, the presence These standards were kindly supplied by Dr Dylan Edwards.
of an acute lesion in the upper cervical spinal cord and the Fifteen per cent polyacrylamide gels were prepared [0.415 ml absence of supratentorial lesions on MRI. The CSF results distilled water, 1.25 ml of 1.5 M Tris (pH 8.8), 100 µl of 10% for the DNO patients are given in Table 1 . Multiple sclerosis SDS, 2.5 ml Protogel solution (30% ultrapure acrylamide-bis; patients had a mean CSF protein concentration of 53.2 Ϯ National Diagnostics, Atlanta, Ga., USA), 2.5 µl TEMED 9.6 mg% and a cell count of 6.4 Ϯ 1.6 mm (mean Ϯ SEM). and 25 µl ammonium persulphate solution, 100 mg/ml], with CSF showed IgG synthesis in the multiple sclerosis patients gelatin (835 µl of 15 mg/ml solution; Sigma G-2500) and with a mean value of 15.2 Ϯ 3.8. Mean CSF protein purified active gelatinase A (0.252 µg/µl; PF023, Calbiochem, concentration for the DNO patients was 45.3 Ϯ 13.5 mg% Cambridge, Mass., USA) copolymerized into the gel matrix. and the mean cell count was 2.8 Ϯ 3.7 mm 3 , which was After electrophoresis, gels were agitated in two washes (both statistically similar to multiple sclerosis patients. Elevated 30 min duration) of 2.5% Triton X-100 to remove the IgG synthesis and oligoclonal bands were absent in the CSF SDS and restore enzyme activity for incubation. Gels were of DNO patients. Some of the multiple sclerosis patients incubated for 16 h at 37°C in 50 µl of 50 mM Tris-HCl were included in an earlier report (Rosenberg et al., 1996) , (pH 7.6, containing 0.2 M NaCl, 5 mM CaCl 2 , 0.02% and several of the DNO patients were also reported earlier and 0.02% sodium azide). Finally, gels were stained for 4 h (Mandler et al., 1993 . The control group comprised in 30% methanol/10% acetic acid/60% H 2 O with 2.5 mg/ml seven patients with non-neurological illnesses undergoing Coomassie G-250, then destained in 10% acetic acid. In the spinal anaesthesia. Because of the small amount of CSF gel, protein bands from TIMPs were evident as darkly stained obtained from controls, only MMPs and TIMPs were bands against a clear background. Dried gels were scanned measured. as described above.
MMP-2 values for the 72-kDa inactive species were measured by zymography only, and were similar in the three groups (multiple sclerosis, 1162 Ϯ 57 relative lysis units; ELISA DNO, 961 Ϯ 88; controls, 1226 Ϯ 97). There were no bands Gelatinase B and TIMP-1 were measured in CSF by the seen with a molecular weight Ͻ72 kDa, indicating the ELISA method (Biotrak, Amersham Life Science, Arlington absence of activated forms of MMP-2 (Fig. 1A) . The highest Heights, Ill., USA) according to the directions included in levels of MMP-9 were found in the CSF of patients with the kits. Results were expressed as ng protein/ml. The ELISA multiple sclerosis (339 Ϯ 52 relative lysis units/mg protein) system we used was designed to detect the proforms of (Fig. 1B) . Values of MMP-9 in patients with multiple sclerosis MMPs that were both free and in complex with TIMPs. The were significantly higher than those found in DNO patients detection limit in CSF for MMP-9 was 0.8 ng/ml. The (114 Ϯ 16) (P Ͻ 0.05) and controls (151 Ϯ 20). MMP-9 detection limit in CSF for TIMP-1 was 1 ng/ml. measured by ELISA was found in only three of the 37 Statistical comparisons were done between the multiple samples, whereas zymography showed the presence of sclerosis, DNO and control groups by ANOVA (analysis of MMP-9 in all but one of the samples (data not shown). In variance) with the Bonferroni correction for multiple t tests addition, an 84-kDa band, representing the active form of (Prism 3.00; GraphPad Software, San Diego, Calif., USA).
the 92-kDa species, was seen in four multiple sclerosis Data are expressed as mean Ϯ standard error of the mean. patients and two controls, but in none of the patients with DNO. Significance was set as a probability of less than 0.05. TIMPs were detected in the CSF of all patients. Reverse levels of MMP-9 in the CSF of multiple sclerosis patients (Gijbels et al., 1992; Paemen et al., 1994; Rosenberg et al. , zymography and ELISA gave similar values for TIMP-1, and the values from the ELISA were used. TIMP-2 was 1996). They are also compatible with the finding that elevated levels of MMP-9 in the serum of multiple sclerosis patients measured only by reverse zymography. TIMP-1 was statistically similar in the three groups (multiple sclerosis, are related to acute attacks (Trojano et al., 1999; Waubant et al., 1999) . 12.0 Ϯ 2.3 ng/ml; DNO, 13.9 Ϯ 4.3 ng/ml; controls, 15.9 Ϯ 1.5 ng/ml) ( Fig. 2A) . TIMP-2 values were also similar in Zymography was more sensitive than ELISA for the detection of MMP-9 (Kleiner and Stetler-Stevenson, 1994) . all three groups (Fig. 2B) .
Separation of the patients with multiple sclerosis into Major differences exist in the two assay methods. ELISA detects inactive forms of the enzyme. Zymography separates groups with relapsing-remitting and secondary progressive disease revealed that the MMP-9 values were significantly molecules by molecular weight, and shows an inactive, higher molecular weight form and a lower active form. The level higher in the relapsing-remitting than in the DNO group (Fig. 3A) . In addition, TIMP-1 values were significantly of sensitivity of the zymograms is in the picogram range, while ELISA is sensitive to nanogram amounts. Reverse lower in the group with multiple sclerosis with a relapsingremitting course than in the control group (Fig. 3B) .
zymography measures active forms of the TIMPs that have blocked the activity of the MMPs, while the ELISA measures inactive forms of MMP-9 (Oliver et al., 1997) . Reverse zymograms and ELISA gave similar results in the
Discussion
We found elevated levels of MMP-9 in the CSF of patients measurement of the TIMPs. All cell types in the brain produce the matrix-degrading with an acute attack of multiple sclerosis, but not in those with DNO, suggesting different pathological mechanisms.
metalloproteinases by the invading leucocytes and macrophages. The enzymes attack all components of the extraThese results suggest an excess of MMP-related proteolytic activity in the brains of multiple sclerosis patients. These cellular matrix, and participate in the opening of the BBB by disrupting the basal lamina around the blood vessels results are consistent with earlier reports showing elevated (Mun-Bryce and Rosenberg, 1998) . MMPs are involved in generally accepted as the diagnosis. Although patients are found in whom the two conditions overlap, there are both the demyelination and the opening of the BBB in experimental allergic encephalomyelitis, and inhibitors of the differences in the clinical course and the pathological findings that support the concept that separate pathological metalloproteinases of the hydroxymate type prevent the BBB damage and reduce clinical symptoms  mechanisms are present. Our finding of reduced levels of the neuroinflammatory marker MMP-9 in the CSF of patients Hewson et al., 1995) .
In addition to the absence of MMP-9, the CSF of patients with DNO is consistent with different disease processes. However, patients with multiple sclerosis showed variability with DNO lacked other markers of acute inflammation, such as elevated IgG synthesis, fragments of myelin basic protein in the levels of MMP-9 in the CSF, which prevented the separation of individual patients on the basis of the MMPs and oligoclonal bands. Leucocytes have been suggested as a possible source for the MMPs (Gijbels et al., 1992) , and alone. TIMPs block the action of the MMPs. Neither TIMP-1 nor TIMP-2 was significantly different in the full group levels of the MMPs in the CSF tend to be higher with leucocytosis. MMP-9 has been shown immunohistoanalysis. However, when the multiple sclerosis patients were separated into subgroups we found a significant reduction of chemically to be present in infiltrating neutrophils and in endothelial cells (Anthony et al., 1997) . Gelatinases are TIMP-1 in the relapsing form of multiple sclerosis compared with DNO. secreted by neutrophils and monocytes, suggesting that they may contribute to the MMP-9 detected in the CSF of Pathological changes differ in patients with multiple sclerosis and DNO. Necrosis and macrophages are seen in patients with multiple sclerosis (Hibbs et al., 1985) . However, considerable experimental evidence suggests that endogenous the cervical spinal cord in DNO, which might suggest involvement of soluble immune mediators, or a vascular sources also contribute to the production of the MMPs. Isolated cerebral capillaries produce MMP-9 during an mechanism. Few inflammatory cells were detected in the CSF of multiple sclerosis patients, suggesting that the MMP-9 inflammatory stimulus (Herron et al., 1986; Harkness et al., 2000) . MMP production takes place when astrocytes and was produced endogenously. There may also be regional differences in the types of cells producing MMPs. microglia in culture receive an inflammatory stimulus (Gottschall and Deb, 1996) . Activated microglia secrete Since DNO is a rare syndrome with diagnostic criteria that vary between clinical centres, a collaborative study with a MMP-9 (Colton et al., 1993) . Thus, brain cells as well as infiltrating leucocytes could be involved in MMP production larger group of patients will be needed to verify these findings. Ideally, a prospective study is needed with patients during neuroinflammation, and further studies will be needed to clarify this. Several of the DNO patients were taking low selected according to similar diagnostic criteria. There may also be differences between MMP production in relapsingdoses of oral prednisone at the time of the lumbar puncture. A recent report showed that oral high-dose methylprednisolone remitting and secondary progressive multiple sclerosis patients that will further complicate the analysis. We propose failed to lower the CSF levels of MMP-9, so it is unlikely that the lower doses affected the CSF findings in our patients that measurement of MMPs in the CSF may provide another parameter to aid in the separation of patients with various (Sellebjerg et al., 2000) .
The relationship of DNO to multiple sclerosis is types of demyelinating process, and may help define the pathophysiological basis for treatment. controversial, complicating the diagnosis of patients with DNO (Mandler et al., 1993; Wingerchuk et al., 1999) . We used the criteria described in our earlier report because the modified criteria appeared after the completion of the study.
